Study of SOC Plus IVIG Compared to SOC Alone in the Treatment of COVID-19
Status:
Completed
Trial end date:
2020-06-23
Target enrollment:
Participant gender:
Summary
The purpose of this research is to see if Intravenous Immunoglobulin (IVIG) can help reduce
respiratory complications (respiratory failure and need for a ventilator) caused by
coronavirus disease 2019 (COVID-19). The principal investigator has successfully utilized
IVIG for patients infected with the influenza virus. The investigator wants to find out if
IVIG is equally effective in COVID-19 infection patients, and if IVIG will give the immune
system some help to clear the infection naturally.